Drug Search Results
More Filters [+]

Difluprednate

Alternative Names: difluprednate, sdn-037, sdn037, sdn 037, durezol
Latest Update: 2024-11-18
Latest Update Note: News Article

Product Description

Difluprednate ophthalmic is used to treat eye swelling and pain after eye surgery. Difluprednate ophthalmic is in a class of medications called corticosteroids. It works by stopping the release of certain natural substances that cause swelling and pain. (Sourced from: https://medlineplus.gov/druginfo/meds/a609025.html)

Mechanisms of Action: GR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical,Ocular,Ophthalmic

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | Canada | Colombia | Dominican Republic | Ecuador | Egypt | France | India | Italy | Korea | Mexico | Peru | Turkey | United Arab Emirates | United States | Uruguay | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Difluprednate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events